UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

       Date of Report (date of earliest event reported): January 14, 2015

                                 AMERICANN, INC.
                 -----------------------------------------------
             (Exact name of registrant as specified in its charter)

        Delaware                       000-54231                27-4336843
   ------------------------        ----------------           ---------------
 (State or other jurisdiction    (Commission File No.)      (IRS Employer
  of incorporation)                                          Identification No.)

                          3200 Brighton Blvd., Unit 144
                                Denver, CO 80216
                -------------------------------------------------
          (Address of principal executive offices, including Zip Code)

       Registrant's telephone number, including area code: (303) 862-9000
                                       --


                             1550 Larimer, Ste. 264
                                Denver, CO 80202
                 ---------------------------------------------
          (Former name or former address if changed since last report)

Check appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below)

[ ]  Written communications pursuant to Rule 425 under the Securities Act (17
     CFR 230.425)

[ ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
     240.14a-12)

[ ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17 CFR 240.14d-2(b))

[ ]  Pre-commencement communications pursuant to Rule 13e-14(c) under the
     Exchange Act (17 CFR 240.13e-4(c))

<PAGE>

Item 1.01.  Entry Into a Material Definitive Agreement

     On January 14,  2015,  the Company  entered into an agreement to purchase a
52.6 acre parcel of undeveloped land in Freetown, Massachusetts. The property is
located approximately 47 miles southeast of Boston. The Company plans to develop
the property as the Massachusetts  Medical Cannabis Center "MMCC". Plans for the
MMCC  may  include  the  construction  of  sustainable  greenhouse  cultivation,
processing,  and  infused  product  facilities  that  will be  leased or sold to
Registered  Marijuana  Dispensaries  under the  Massachusetts  Medical Marijuana
Program.  Additional  plans for the MMCC may  include a  testing  laboratory,  a
research facility, a training center and corporate offices.

     The Company  paid the seller  $100,000  upon the  signing of the  agreement
which amount will be applied  toward the  purchase  price of  $4,000,000  at the
closing. The closing must take place on or before June 1, 2015.

     The Company  plans to develop  comparable  facilities  in other states that
allow for the production and sale of cannabis.  The Company's ability to develop
the MMCC, as well as its plans for other states,  is contingent upon its ability
to obtain the capital required to fund the projects.

     The Company does not cultivate, process or sell marijuana.

                                       2
<PAGE>

                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

Date: February 12, 2015
                                     AMERICANN, INC.


                                      By:/s/ Timothy Keogh
                                         --------------------------------------
                                         Timothy Keogh, Chief Executive Officer
[{"type": "8-K", "sequence": "1", "filename": "form8kitem101feb-15.txt", "description": "8-K ITEM 1.01", "secsgml_size_bytes": 4046}]
{"company-data": {"conformed-name": "Americann, Inc.", "cik": "0001508348", "assigned-sic": "6770", "irs-number": "274336843", "state-of-incorporation": "DE", "fiscal-year-end": "0930"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-54231", "film-number": "15616004"}, "business-address": {"street1": "1550 LARIMER", "street2": "SUITE 264", "city": "DENVER", "state": "CO", "zip": "80202", "phone": "(303) 839-0061"}, "mail-address": {"street1": "1550 LARIMER", "street2": "SUITE 264", "city": "DENVER", "state": "CO", "zip": "80202"}, "former-company": {"former-conformed-name": "Nevada Health Scan, Inc.", "date-changed": "20101220"}}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

       Date of Report (date of earliest event reported): January 14, 2015

                                 AMERICANN, INC.
                 -----------------------------------------------
             (Exact name of registrant as specified in its charter)

        Delaware                       000-54231                27-4336843
   ------------------------        ----------------           ---------------
 (State or other jurisdiction    (Commission File No.)      (IRS Employer
  of incorporation)                                          Identification No.)

                          3200 Brighton Blvd., Unit 144
                                Denver, CO 80216
                -------------------------------------------------
          (Address of principal executive offices, including Zip Code)

       Registrant's telephone number, including area code: (303) 862-9000
                                       --

                             1550 Larimer, Ste. 264
                                Denver, CO 80202
                 ---------------------------------------------
          (Former name or former address if changed since last report)

Check appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below)

[ ]  Written communications pursuant to Rule 425 under the Securities Act (17
     CFR 230.425)

[ ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
     240.14a-12)

[ ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17 CFR 240.14d-2(b))

[ ]  Pre-commencement communications pursuant to Rule 13e-14(c) under the
     Exchange Act (17 CFR 240.13e-4(c))
Item 1.01.  Entry Into a Material Definitive Agreement

     On January 14,  2015,  the Company  entered into an agreement to purchase a
52.6 acre parcel of undeveloped land in Freetown, Massachusetts. The property is
located approximately 47 miles southeast of Boston. The Company plans to develop
the property as the Massachusetts  Medical Cannabis Center "MMCC". Plans for the
MMCC  may  include  the  construction  of  sustainable  greenhouse  cultivation,
processing,  and  infused  product  facilities  that  will be  leased or sold to
Registered  Marijuana  Dispensaries  under the  Massachusetts  Medical Marijuana
Program.  Additional  plans for the MMCC may  include a  testing  laboratory,  a
research facility, a training center and corporate offices.

     The Company  paid the seller  $100,000  upon the  signing of the  agreement
which amount will be applied  toward the  purchase  price of  $4,000,000  at the
closing. The closing must take place on or before June 1, 2015.

     The Company  plans to develop  comparable  facilities  in other states that
allow for the production and sale of cannabis.  The Company's ability to develop
the MMCC, as well as its plans for other states,  is contingent upon its ability
to obtain the capital required to fund the projects.

     The Company does not cultivate, process or sell marijuana.

                                       2
SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

Date: February 12, 2015
                                     AMERICANN, INC.

                                      By:/s/ Timothy Keogh
                                         --------------------------------------
                                         Timothy Keogh, Chief Executive Officer